8-58808157-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014729.3(TOX):c.1505C>A(p.Pro502Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000607 in 1,613,918 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014729.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TOX | NM_014729.3 | c.1505C>A | p.Pro502Gln | missense_variant | 8/9 | ENST00000361421.2 | NP_055544.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TOX | ENST00000361421.2 | c.1505C>A | p.Pro502Gln | missense_variant | 8/9 | 1 | NM_014729.3 | ENSP00000354842.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000877 AC: 22AN: 250840Hom.: 1 AF XY: 0.000103 AC XY: 14AN XY: 135526
GnomAD4 exome AF: 0.0000643 AC: 94AN: 1461706Hom.: 1 Cov.: 31 AF XY: 0.0000688 AC XY: 50AN XY: 727140
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2021 | The c.1505C>A (p.P502Q) alteration is located in exon 8 (coding exon 8) of the TOX gene. This alteration results from a C to A substitution at nucleotide position 1505, causing the proline (P) at amino acid position 502 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at